Innate Pharma (IPH) — Cash Flow-to-Debt Ratio
Innate Pharma (IPH) has a Cash Flow-to-Debt Ratio of -0.26x as of December 2025, meaning its operating cash flow of €-21.59 Million could theoretically repay 0% of its total liabilities (€84.42 Million) in one year. See Innate Pharma free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Innate Pharma Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for Innate Pharma across 21 annual periods. Also explore Innate Pharma (IPH) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Innate Pharma (2005–2025)
Year-by-year debt coverage analysis for Innate Pharma. For market capitalisation and broader financial context, see Innate Pharma stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.62x | €-52.76 Million | €84.42 Million | ▼ -826.3% |
| 2024 | -0.07x | €-6.90 Million | €102.22 Million | ▲ +72.6% |
| 2023 | -0.25x | €-32.56 Million | €132.29 Million | ▼ -97.5% |
| 2022 | -0.12x | €-19.15 Million | €153.71 Million | ▲ +65.9% |
| 2021 | -0.37x | €-58.46 Million | €160.06 Million | ▼ -6.8% |
| 2020 | -0.34x | €-51.81 Million | €151.45 Million | ▼ -280.2% |
| 2019 | 0.19x | €34.92 Million | €183.94 Million | ▲ +265.7% |
| 2018 | -0.11x | €-32.53 Million | €283.98 Million | ▲ +59.7% |
| 2017 | -0.28x | €-48.06 Million | €169.07 Million | ▼ -50.7% |
| 2016 | -0.19x | €-36.85 Million | €195.41 Million | ▼ -121.2% |
| 2015 | 0.89x | €207.91 Million | €233.89 Million | ▲ +178.7% |
| 2014 | -1.13x | €-18.13 Million | €16.06 Million | ▼ -60.5% |
| 2013 | -0.70x | €-10.97 Million | €15.60 Million | ▼ -67.4% |
| 2012 | -0.42x | €-10.47 Million | €24.93 Million | ▼ -208.3% |
| 2011 | 0.39x | €12.99 Million | €33.48 Million | ▲ +141.8% |
| 2010 | -0.93x | €-13.45 Million | €14.49 Million | ▼ -167.3% |
| 2009 | -0.35x | €-5.94 Million | €17.10 Million | ▲ +54.0% |
| 2008 | -0.76x | €-14.74 Million | €19.52 Million | ▼ -10.2% |
| 2007 | -0.69x | €-9.28 Million | €13.55 Million | ▼ -2552.5% |
| 2006 | 0.03x | €360.00K | €12.89 Million | ▲ +101.8% |
| 2005 | -1.54x | €-7.25 Million | €4.70 Million | — |